CytoDyn Inc. (OTCMKTS: CYDY) Treats the First patient With Leronlimab in Phase 3 Severe COVID-19 Study
CytoDyn Inc. (OTCMKTS: CYDY) has announced the treatment of the first patient in the pivotal third phase COIVID-19 study in Brazil for patients showing severe symptoms. The company plans to…
CytoDyn Inc (OTCMKTS: CYDY) Stockholders Address a Misleading Company Press Release
Long-time CytoDyn Inc (OTCMKTS: CYDY) stockholders that have been involved in nominating around 5 vastly experienced director candidates to be placed on the Board of Directors of the company recently…